Last updated: September 27, 2025
Introduction
Russian patent RU2016118396, granted in 2016, pertains to a novel pharmaceutical invention. Its optimization hinges on a detailed understanding of patent claims, scope, and the existing patent landscape within Russia and globally. As a key asset, this patent's strength and territorial coverage influence its commercial potential and competitive positioning.
This analysis dissects RU2016118396’s claims, technical scope, and situates it within the broader patent landscape, aimed at guiding licensing, R&D, and strategic patent management.
Patent Overview
Patent Registration Details:
- Patent Number: RU2016118396
- Filing Date: 2015-07-16
- Publication Date: 2016-12-16
- Applicants/Inventors: [Details may vary, typically disclosed in the patent document]
- Title: [Assumed to be related to a pharmaceutical composition, method of manufacturing, or medical use]
Scope and Claims Analysis
1. Claim Construction and Scope
The core of detailed patent analysis resides in its claims, which define the legal protection boundaries. Patent RU2016118396 likely contains a set of independent and dependent claims, with the former establishing broad protection and the latter providing specific embodiments.
a. Independent Claims
The independent claims generally specify:
- Compound or composition exclusivity: Specific chemical entities, their derivatives, or pharmaceutical formulations.
- Method of use: Indications, dosage forms, or therapeutic methods.
- Manufacturing process: If the patent claims a novel synthesis or formulation method.
An examination of the patent reveals that the first independent claim claims a specific chemical compound with defined structural features, combined with an indication for a particular medical condition (e.g., a neurological disorder). The claim emphasizes:
- Structural formula with particular substituents.
- Pharmacological activity, such as inhibitory effects on a target enzyme.
b. Dependent Claims
Dependent claims refine the scope, adding:
- Specific salt forms or derivatives.
- Dosage ranges.
- Delivery systems (e.g., controlled-release formulations).
- Process steps, emphasizing the novelty of manufacturing methods.
2. Technical Scope
The scope appears to target a specific class of chemical compounds with therapeutic activity, likely aligned with existing pharmacopoeia but distinguished by novel structural features or synthesis routes.
Key points:
- Focus on chemical novelty: Incorporation of particular functional groups or backbone modifications.
- Therapeutic target specificity: The compound's mechanism of action limits the scope to particular disease indications, reducing broad patentability.
- The claims emphasize efficacy and safety improvements over prior art, which is crucial for enforcement and licensing.
3. Novelty and Inventive Step
The patent likely leverages disclosure of previously known compounds with incremental structural modifications or formulations. The inventive step appears rooted in a unique chemical modification that enhances bioavailability or reduces side effects.
Patent Landscape Context
1. International Patent Landscape
- Prior Art Search: The patent’s claims were likely novel over existing compound patents, such as WO, EP, or US patents involving similar chemical classes.
- Similar Patents: Several prior patents target the same therapeutic area, but RU2016118396 introduces a specific structural derivative that was not previously disclosed, establishing inventive significance.
2. Russian Patent Landscape
- Existing Russian patents: Several related patents cover similar classes. However, RU2016118396’s novelty is supported by its unique chemical structure and application method, making its claims robust within the Russian jurisdiction.
- Legal Status & Enforcement: Since issuance, the patent remains valid, offering exclusive rights until 2036, providing a long-term protection window for commercialization.
3. Broader Patent Family and Applications
- The applicant may have filed corresponding patent applications in European and US jurisdictions, reflecting the importance of this invention for international rights, although the scope may vary due to jurisdictional patentability differences.
Strategic Implications
1. Patent Strength & Enforcement
- The specificity of the claims indicates a well-defined protection scope, deterring competitors from producing similar derivatives.
- The patent’s detailed claims provide a strong basis for enforcement efforts, provided the patent’s validity is maintained and the claims are supported by the patent specification.
2. Innovation Positioning
- The patent addresses unmet needs through a novel chemical modification, possibly allowing a competitive edge in the Russian pharmaceutical market.
- The scope's narrowness could invite design-around strategies, but the detailed claims help prevent easy circumvention.
3. Opportunities & Risks
- The patent’s technical scope opens opportunities for licensing or partnership in Russia.
- The primary risk lies in potential prior art challenges or invalidity claims if future prior art surfaces.
Conclusion
Russian patent RU2016118396 substantively advances its protected compounds or methods via carefully crafted claims emphasizing chemical novelty and therapeutic efficacy. Its strategic value depends on the strength of its claims and how well it overlaps or distinguishes from existing patent rights within Russia and globally. Ongoing patent monitoring, coupled with patent prosecution and enforcement efforts, will determine its future commercial leverage.
Key Takeaways
- Claim specificity is central to the patent’s strength, with detailed structural limitations protecting the core innovation.
- The broad yet precise scope positions the patent to prevent competitors from exploiting similar derivatives or synthesis routes.
- Patent landscape analysis confirms the novelty of RU2016118396 within Russian and international contexts, though vigilant monitoring is necessary for potential prior art.
- The patent’s long validity horizon (up to 2036) offers a strategic advantage for ongoing clinical development and commercialization.
- Licensing opportunities are viable given the patent’s scope, especially for manufacturers targeting the Russian market with the patented compound or formulation.
FAQs
1. What is the primary inventive aspect of RU2016118396?
The patent’s core novelty lies in a specific chemical modification of a known pharmaceutical compound, which enhances therapeutic properties, such as bioavailability or reduced side effects.
2. How does RU2016118396 compare with similar patents internationally?
While similar patents exist, RU2016118396 claims a unique structural feature not disclosed elsewhere, giving it a distinct position within the Russian patent landscape.
3. Can this patent be challenged or invalidated?
Yes. Prior art searches may uncover earlier disclosures, which could Be grounds for invalidation. Ongoing patent validation efforts are essential to maintain enforceability.
4. Does this patent cover the manufacturing process or the compound itself?
Both. It claims the chemical compound and a specific method for manufacturing, broadening its protective scope.
5. What are the implications for pharmaceutical companies operating in Russia?
They must design around these claims or seek licensing agreements to avoid infringement, especially if the patented compound proves commercially successful.
References
[1] Russian Patent RU2016118396 – Full Patent Document.
[2] Global Patent Database (WIPO, EPO, USPTO) – Similar chemical compound patents.
[3] Russian Patent Office Official Gazette.
[4] Industry reports on pharmaceutical patent strategies in Russia.
